INDBInternet News Database 2.5 Updated 1 min ago · 324 sources Show or hide images Light or dark

Early Mepolizumab to Induce EGPA Remission May Pay Off

Save Like Comments Compare coverage

Summary

Mepolizumab treatment in early EGPA may not beat conventional therapy in inducing remission, but its use may pay off later at 1 year and lead to reduced steroid use.

Description from Medscape.

Who is covering this

  1. Medscape Center Factuality: Mostly factual US
    Early Mepolizumab to Induce EGPA Remission May Pay Off

    Mepolizumab treatment in early EGPA may not beat conventional therapy in inducing remission, but its use may pay off later at 1 year and lead to reduced steroid use.

Comments

Comments need JavaScript.